A study published in the Journal of JAMA Health Forum has found a slight decrease in obesity rates among US adults, with women aged 66-75 in the South experiencing the most significant drop. Researchers attribute this decline to increased use of weight-loss medications like semaglutide (Ozempic), although caution is needed due to potential confounding factors such as COVID-19 mortality rates. The study highlights the need for alternative measures beyond Body Mass Index (BMI) to better understand obesity trends.
Source: https://komonews.com/news/nation-world/fact-check-team-us-obesity-rates-see-first-decline-in-over-a-decade-healthcare-wellness-medication-ozempic